"Setting a HIRE standard...that's the Dunhill difference."
J&J hit with $1.2 billion penalty in drug case

An Arkansas judge slapped Johnson & Johnson and a subsidiary with more than $1.2 billion in penalties on Wednesday for deceptive marketing of the antipsychotic drug Risperdal.